A Study of Icatibant in Patients With Acute Attacks of Hereditary Angioedema (FAST-3)

NCT00912093 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

98

Enrollment

INDUSTRY

Sponsor class

Conditions

Hereditary Angioedema

Interventions

DRUG: Icatibant
DRUG: Placebo

Sponsor

Shire